Puma Biotechnology (PBYI) Other Working Capital Changes (2018 - 2026)

Puma Biotechnology (PBYI) has 9 years of Other Working Capital Changes data on file, last reported at -$60000.0 in Q1 2026.

• Quarterly Other Working Capital Changes fell 957.14% year-over-year to -$60000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $98000.0 (up 162.42% YoY) and the FY2025 annual result came in at $165000.0, up 120.1% from the prior year.
• Other Working Capital Changes fell to -$60000.0 in Q1 2026, from $26000.0 in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $3.7 million in Q2 2022 to a low of -$2.0 million in Q1 2023.
• A 5-year average of -$14764.7 and a median of -$14000.0 in 2024 frame the typical range for Other Working Capital Changes.
• The widest YoY moves for Other Working Capital Changes: up 3385.71% in 2022, down 41925.0% in 2022.
• Tracing PBYI's Other Working Capital Changes over 5 years: stood at -$1.7 million in 2022, then soared by 35.99% to -$1.1 million in 2023, then jumped by 86.52% to -$145000.0 in 2024, then surged by 117.93% to $26000.0 in 2025, then tumbled by 330.77% to -$60000.0 in 2026.
• The last three Other Working Capital Changes figures came in at -$60000.0 (Q1 2026), $26000.0 (Q4 2025), and $157000.0 (Q3 2025), per Business Quant data.